• The Democratic Republic of Congo's Ebola outbreak reached 7,200 confirmed cases and 3,475 deaths (ECDC, data as of Sep 12) across 62 of 167 health zones in seven provinces — 258 new cases and 126 new deaths in the Sep 10-12 window alone.
• Government spokesman Patrick Muyaya, citing Health Minister Roger Kamba, said Sep 12: "The 17th Ebola outbreak is under control, and the peak was reached at the beginning of the third week of August 2026," citing 10 of 61 health zones with no new cases for at least 21 days.
• The WHO directly disputed that characterization, saying the outbreak "remains uncontrolled and increasingly heterogeneous," with transmission easing in some areas while intensifying in others.
• South-Ubangi was confirmed as a seventh affected province; schools in Bunia reported new cases after reopening, prompting hand-washing stations and reduced classroom capacity.
• A near-simultaneous AFP-wire count (Sep 13) put the toll slightly lower, at 7,022 cases and 3,398 deaths, from the same government source stream.

Background: the outbreak, the largest in DRC's history, was declared a public health emergency of international concern on May 17.

Spin: the Congolese government's "peaked and under control" framing, resting on the 21-day-quiet health zones, against the WHO's "uncontrolled and increasingly heterogeneous" characterization of the same reporting window.

Omissions: none found

Unreported: no agency has reconciled the AFP wire's count (7,022/3,398, released Sep 13) against ECDC's figure (7,200/3,475, data as of Sep 12), though both trace to the same Congolese source stream.

Inaccuracies: none found

What it could mean:

• Popular frame: the DRC's worst-ever Ebola outbreak has passed its peak and is subsiding.
• Counter: the WHO's own same-week assessment calls the outbreak "uncontrolled and increasingly heterogeneous," and ECDC's case count grew by 258 in the 48 hours just before the government's "peaked" statement — the quiet zones the government cites coexist with continued net growth elsewhere.
• Documented: Muyaya and Kamba's public statement is itself the documented government position.
• Inferred: the "peaked" framing, delivered the same week the outbreak spread to a seventh province, suggests a political incentive to signal progress independent of the underlying trend.

Where it stands: case totals continue to rise in ECDC's own data even as the government maintains the outbreak has peaked; the WHO's dispute of that claim is unresolved.

• DRC's Institut National de Santé Publique reported 7,022 confirmed Ebola cases and 3,398 deaths as of Sep 10 — a 48.4% case-fatality rate — across 62 health zones in seven provinces.
• On Sep 10 alone, health authorities recorded 80 new confirmed cases and 49 deaths.
• The outbreak's newest province, Sud-Ubangi, confirmed its first case Sep 10: a 23-year-old man who had traveled from South Kivu and on to Rwanda and Uganda before falling ill; he died. Sud-Ubangi borders none of the other six affected provinces.
• DRC government spokesperson Patrick Muyaya, citing Health Minister Roger Kamba, said Sep 13 the outbreak "is under control, and the peak was reached at the beginning of the third week of August."
• The World Health Organization's own assessment from the same period describes the outbreak as remaining "uncontrolled and increasingly heterogeneous."

Spin: the DRC government framing the outbreak as under control and past its peak, against the World Health Organization's own concurrent description of it as uncontrolled and increasingly heterogeneous — arriving the same week the outbreak reached a seventh province with no border to the other six.

Omissions: none found

Unreported: no outlet reconciles the government's under-control claim with the same-week jump to a seventh, non-adjacent province.

Inaccuracies: none found

What it could mean:

• Popular frame: the DRC government's Sep 13 statement that the outbreak is under control and has passed its peak.
• Counter: WHO's own concurrent assessment calls the outbreak uncontrolled and increasingly heterogeneous, and the case count just reached a seventh province sharing no border with the other six — a pattern inconsistent with a contained, past-peak epidemic.
• Documented: the DRC government's own statement asserts control, an assessment it states for itself.
• Inferred: declaring the outbreak past its peak ahead of WHO's own confirmation may reflect pressure to restore public confidence while the case count keeps climbing.

Where it stands: the outbreak has surpassed 7,000 cases and 3,400 deaths with the government's "under control" claim not independently confirmed by WHO. Background: the DRC's 17th Ebola epidemic, caused by the rare Bundibugyo strain for which no vaccine is approved, was declared a public health emergency May 17 and is the deadliest in the country's history.

• ECDC's primary figures, as of Sep 9: 6,942 confirmed cases and 3,349 deaths — a case-fatality rate near 48% — across six provinces and 61 of the country's 151 health zones.
• Ituri remains worst-hit (5,508 cases, 2,501 deaths), followed by North Kivu (1,139 cases, 725 deaths); Haut-Uélé, Tshopo, Bas-Uélé and South Kivu carry the remainder.
• A new case in South-Ubangi province, reported Sep 10, with travel history within DR Congo and to Rwanda and Uganda, extends the outbreak to a seventh province.
• No fresher aggregate than the Sep 9 ECDC figures has been published as of Sep 12.

Background: the DR Congo Ebola outbreak, the largest in the country's history, was declared a Public Health Emergency of International Concern on May 17.

Spin: none

Omissions: none found

Unreported: the mechanism of the South-Ubangi case's spread — whether administrative reporting lag, healthcare-worker transmission, or new community spread; updated vaccination-uptake figures from the Kisangani Ervebo campaign, which began roughly two weeks ago.

Inaccuracies: none found

What it could mean:

• Popular frame: the outbreak is expanding toward uncontrolled, regional spread as healthcare systems are overwhelmed.
• Counter: a new province confirmed via travel history may reflect a single traced case rather than new sustained transmission, and the outbreak's continuing international response — a Phase 3 vaccine trial and cross-border coordination — shows the response has not collapsed even as the case count rises.
• Documented: WHO and the Congolese health ministry continue to treat the outbreak as requiring an escalated international response, including the ongoing $1.1 billion funding gap they have publicly cited.
• Inferred: continuing urgency in international messaging may in part reflect pressure to close that funding gap, independent of whether the epidemiological trend has actually worsened week to week.

Where it stands: the outbreak remains active in seven provinces; the next ECDC or WHO update will be the first test of whether South-Ubangi represents a contained single case or the start of new spread.

• ECDC published an updated outbreak page for the Democratic Republic of Congo.

Background: the Democratic Republic of Congo is managing an Ebola outbreak.

Spin: institutional monitoring versus unanswered response-capacity questions.

Omissions: No left-leaning coverage found. No right-leaning coverage found. No center or wire coverage found.

Unreported: a fresher reconciled national aggregate and vaccine-effectiveness result.

Inaccuracies: none found

What it could mean:

• Popular frame: an institutional update settles the outbreak.
• Counter: surveillance still needs local and independent corroboration.
• Documented: ECDC published an outbreak update.
• Inferred: institutions are maintaining attention while uncertainty remains.

Where it stands: the update is public; no reader health guidance is offered here.

• ECDC updated its page Sep 9 using the DRC's Sep 8 situation report for data through Sep 7: 6,757 confirmed cases, 3,267 related deaths, 813 people in isolation and 1,590 recoveries.
• The agency says the case and death data remain under review and harmonisation; it reports 88.3% of contacts followed.

Background: a Bundibugyo-virus Ebola outbreak has affected the Democratic Republic of Congo and Uganda.

Spin: visible response progress versus an outbreak whose core totals remain provisional.

Omissions: none found

Unreported: a final fatality rate and proof that any named intervention caused the reported changes.

Inaccuracies: none found

What it could mean:

• Popular frame: response activity means transmission has been resolved.
• Counter: ECDC explicitly says its totals are still under review and harmonisation.

Where it stands: ECDC is the single independent source supporting this account. Its Sep 9 page carries data through Sep 7 from the DRC's Sep 8 report; the figures are not final.

• ECDC updated its page Sep. 9 using the DRC's Sep. 8 situation report for data through Sep. 7: 6,757 confirmed cases, 3,267 related deaths, 813 people in isolation and 1,590 recoveries.
• The agency says the case and death data remain under review and harmonisation; it reports 88.3% of contacts followed.

Background: a Bundibugyo-virus Ebola outbreak has affected the Democratic Republic of Congo and Uganda.

Spin: visible response progress versus an outbreak whose core totals remain provisional.

Omissions: none found

Unreported: a final fatality rate and proof that any named intervention caused the reported changes.

Inaccuracies: none found

What it could mean:

• Popular frame: response activity means transmission has been resolved.
• Counter: ECDC explicitly says its totals are still under review and harmonisation.

Where it stands: ECDC is the single independent source supporting this account. Its Sep. 9 page carries data through Sep. 7 from the DRC's Sep. 8 report; the figures are not final.

• WHO’s Sep. 6 report added 586 confirmed cases and 276 confirmed deaths in the Democratic Republic of the Congo.
• It put the cumulative total at 6,686 confirmed cases and 3,226 deaths.

Background: The Bundibugyo-virus outbreak in eastern Congo has expanded rapidly since May.

Spin: WHO emphasizes expanded care capacity; recent reporting emphasizes that transmission continues to outpace containment.

Omissions: none found

Unreported: The current WHO material does not show that expanded capacity has reduced transmission.

Inaccuracies: none found

What it could mean:

• Popular frame: More beds and staff show the response is catching up.
• Counter: The same report adds 586 cases and 276 deaths; expanded capacity is not evidence of containment.
• Documented: WHO said teams are increasing beds and strengthening care teams.
• Inferred: The expansion may reduce treatment delays, but its effect has not been demonstrated.

Where it stands: WHO’s Sep. 6 report is the current count anchor.

ECDC's outbreak page now shows 6,604 confirmed cases and 3,175 deaths in DRC as of Sept. 5, up from 6,342/3,072 — the outbreak-wide case-fatality rate is about 48%; North Kivu specifically runs about 66%, still unexplained.

Background: the outbreak was declared a Public Health Emergency of International Concern in May and is the largest Ebola outbreak in DRC's history.

Spin: none

Omissions: none found

Unreported: none found

Inaccuracies: none found

What it could mean:

• Popular frame: the outbreak's growth is a routine, expected feature of an epidemic already declared the largest in DRC's history.
• Counter: North Kivu's roughly 66% case-fatality rate remains sharply above the outbreak-wide 48% with no explanation identified by WHO or any outlet found — an unresolved anomaly, not routine variation.

Where it stands: case and death counts continue climbing with North Kivu's elevated fatality rate still unexplained.

• The outbreak's toll reached 6,342 cases and 3,072 deaths as of Sep 2, per the ECDC's latest sitrep, up from 6,250/3,039 — a one-day rise of 92 cases and 33 deaths.
• Ituri province remains worst-hit, with 5,164 cases and 2,342 deaths; North Kivu's case-fatality rate remains an outlier at 68%.

Background: the outbreak, DR Congo's largest on record, has no approved vaccine for this Ebola strain and is being fought with an experimental vaccine trial alongside the licensed Ervebo vaccine.

Spin: none

Omissions: none found

Unreported: No outlet has published current Phase 3 vaccine-trial enrollment figures beyond the initial 20,000-dose allocation.

Inaccuracies: none found

What it could mean:

• Popular frame: The outbreak response is scaling up and gradually gaining ground on the virus's spread.
• Counter: The daily case-growth rate has not meaningfully slowed, North Kivu's 68% case-fatality rate remains unexplained, and the response's own $1.1 billion funding gap is unresolved.
• Documented: UN relief chief Tom Fletcher said Sep 1: "The response is growing and has been scaled up, but the virus is moving faster."
• Inferred: The unexplained North Kivu fatality rate suggests treatment-access or care-quality gaps beyond what current reporting has investigated.

Where it stands: Case and death counts continue rising daily; the funding gap and the North Kivu fatality-rate anomaly remain unresolved.

• DRC's Sep 3 sitrep (data through Sep 2) puts the outbreak at 6,342 confirmed cases and 3,072 deaths, up 92 cases and 33 deaths in a day. Ituri province remains worst-hit, with 5,164 cases and 2,342 deaths. 770 patients are hospitalized in isolation, and 1,475 have recovered.

Background: DRC's Bundibugyo-virus Ebola outbreak, the largest in the country's history, was declared a PHEIC in May.

Spin: none

Omissions: none found

Unreported: none found

Inaccuracies: none found

What it could mean:

• Popular frame: WHO's new mobile-phone movement-data method for predicting new clusters is framed as strengthening the response.
• Counter: The case count still grew by 92 in a single day with that tool already in place, showing transmission has not yet been brought under the control the method aims for.

Where it stands: cases continue rising; North Kivu's high case-fatality rate remains under WHO investigation, unexplained.

• DRC's latest confirmed count reached 6,250 cases and 3,039 deaths (data through Sep 1), up from 6,186/3,007 the prior update.
• WHO and partners have begun using anonymized mobile-phone movement data to predict where new outbreak clusters may emerge, a method not previously used in an Ebola response, aimed at tracking transient mine workers and displaced populations.

Background: the DRC is fighting the largest Ebola outbreak in its history, now past 3,000 deaths, with a $1.1 billion WHO funding gap still unresolved.

Spin: none

Omissions: NPR and Breitbart, which each covered every prior major case-count threshold in this outbreak, carried no coverage found of the death toll passing 3,000; Washington Post and NBC News both did.

Unreported: None found

Inaccuracies: None found

What it could mean:

• Popular frame: the outbreak's growth is being tracked and contained with the tools already in place.
• Counter: WHO's decision to add mobile-phone tracking — a method never before used in an Ebola response — is itself evidence the existing tools were not sufficient to predict where the outbreak spreads next.

Where it stands: case and death counts continue rising daily; North Kivu's elevated fatality rate remains under WHO investigation with no explanation yet published.

• DRC's health ministry's latest situation report (data through Aug 31, published Sep 1) puts the outbreak at 6,186 confirmed cases and 3,007 deaths, up from 6,100/2,950 the day before — a single-day rise of 86 cases and 57 deaths.
• WHO Director-General Tedros told reporters in Geneva (Sep 2) that deaths have passed 3,000 and that "there are chains of transmission we don't know about," reiterating the response's $1.1 billion funding gap.
• The CDC assessed that up to 80% of new cases are occurring outside known contacts — containment is running "below established response targets."
• North Kivu carries 868 cases and 589 deaths, a 67.9% case-fatality rate, still the highest of any province and still under WHO investigation with no explanation reported.
• Schools reopened this week in the worst-hit areas after DRC officials concluded remote learning would harm students more than the Ebola risk.

Background: Ervebo vaccination of health workers began in Kisangani on Aug 27, with no uptake data published more than a week later.

Spin: WHO/UN officials and Al Jazeera's reporting frame the outbreak as a response-and-funding failure — the funding gap, "chains of transmission we don't know about." The AP wire's coverage, carried by Washington Times and NBC, frames the same period around the death-toll milestone alone, without the response-failure framing.

Omissions: The CDC's finding that up to 80% of new cases fall outside known contact networks, carried by Al Jazeera's Sep 2 report, is absent from the AP wire coverage carried by Washington Times and NBC, which lead with the death-toll milestone alone.

Unreported: No outlet has reported enrollment or uptake figures for the Ervebo healthcare-worker vaccination campaign that began Aug 27 in Kisangani, more than a week after it started.

Inaccuracies: None found

What it could mean:

• Popular frame: the response is scaling up to meet the outbreak.
• Counter: the CDC's 80%-outside-known-contacts finding and Tedros's own "chains of transmission we don't know about" line indicate the response is not tracking the outbreak's actual spread — a surveillance failure, not only a funding one.

Where it stands: The outbreak continues to outpace the response by WHO's own account, with North Kivu's elevated fatality rate still unexplained and no fresh vaccination uptake data more than a week into the Kisangani campaign.

• ECDC's Sept 1 update, citing DRC data through Aug 30, puts the outbreak at 6,100 confirmed cases, 2,950 deaths, 1,383 recoveries, 814 hospitalized in isolation, and 86.3% contact-tracing follow-up — all risen from the prior figures.
• UN News quoted UN Emergency Relief Coordinator Tom Fletcher comparing the outbreak's first 100 days (5,515 cases/2,642 deaths) to the 2014-16 West Africa Ebola epidemic's first 100 days (635/399), and reiterated a $1.1 billion funding gap; MONUSCO is expanding access programs for more than 60,000 people in Djugu territory.
• Ervebo vaccination of health workers began Aug 27 in Kisangani; no uptake numbers have been published yet, and the campaign is roughly a week old. WHO's Technical Advisory Group also cited preliminary animal data: 3 of 4 Ervebo-vaccinated macaques survived a Bundibugyo-strain challenge, versus 1 of 4 unvaccinated controls.
• North Kivu's outlying 68% case-fatality rate remains unexplained, still under WHO investigation with no public finding.

Background: Aug 26–28 — Uganda's linked outbreak declared over; France's imported case completed monitoring.

Spin: none

Omissions: UN News's 100-day comparison and the MONUSCO access-program detail are absent from Breitbart's most recent dedicated coverage (Aug 31), which reported only the bare case and death figures. No left-leaning coverage found today. No center or wire coverage found today.

Unreported: No Ervebo uptake or coverage figure exists yet for Kisangani health workers.

Inaccuracies: None found

What it could mean: WHO's own formal risk assessment continues to rate the outbreak's risk of spread beyond DRC's borders as low despite the record pace of growth — offered here as the counter to an escalating-global-threat framing, since no outlet reviewed argues the opposite.

Where it stands: the outbreak has passed 6,100 cases and 2,950 deaths, spreading roughly nine times faster in its first 100 days than the 2014-16 West Africa epidemic did in its own, with the funding gap and the unexplained North Kivu mortality rate both still unresolved.

• Two competing same-day aggregates: DRC's Ministry of Communication and Media (Aug 31, real-time): 6,041 confirmed cases, 2,911 deaths, 1,366 recoveries, contact tracing 82.4%. ECDC's aggregate (posted Aug 31, data through Aug 28): 5,945 cases, 2,862 deaths, CFR 48.1% (unchanged), 84.4% contact tracing. The roughly 100-case/50-death gap reflects ECDC's ~3-day reporting lag against DRC's same-day figures, not a correction.

• No fresh Ervebo vaccination-uptake figures were found beyond the Aug 27–28 campaign-launch dose allocations (70,000 doses: 50,000 for frontline/health workers, 20,000 for the Phase 3 trial).

Background: Aug 26 — WHO declared Uganda's linked outbreak over; France's imported case completed monitoring, leaving the active outbreak DRC-only.

Spin: Breitbart's coverage (right-of-center) emphasizes local dysfunction — distrust of foreign aid workers, attacks on quarantine sites, body theft, health-worker strikes over pay/protection — while reassuring on low US risk, quoting CDC directly. Left-leaning and wire coverage (NBC/AP, Al Jazeera) stays largely statistical, with no strong equity- or funding-critique frame found today.

Omissions: none identified beyond the standing gap in Ervebo uptake data.

Unreported: North Kivu's outlying 68% case-fatality rate remains unexplained; WHO's investigation into it has not yet produced a public finding.

Inaccuracies: None found

What it could mean:

• Documented — two official aggregates published the same day differ by roughly 100 cases due to reporting-lag alone.
• Inferred, falsifiable — this gap could mislead casual readers into treating it as a data-quality problem rather than a timing artifact; falsified if a future digest cycle finds the gap widening for reasons other than lag.
• Counter: none needed — this is a low-stakes methodological note, not a contested claim.

Where it stands: the outbreak has crossed 6,000 cases and is nearing 3,000 deaths per DRC's government tally; the standing right-of-center coverage gap has closed.

• WHO's formal Disease Outbreak News (DON616, published Aug 28, data through Aug 26): 5,794 confirmed cases / 2,786 deaths in DRC, crude case-fatality rate 48.1% — highest sub-national CFR is North Kivu at 68%, "under investigation."
• Cross-border cumulative total (DRC + Uganda + France + Germany-treated cases): 5,815 cases, 2,788 deaths, 1,314 recovered.
• WHO formally declared Uganda's linked outbreak over on Aug 26, after the 42-day no-new-case countdown completed Jul 28; France's imported case also completed its 42-day monitoring Aug 27 — the active outbreak is now DRC-only.
• Contact tracing: 82.3% of contacts followed up (22,091 of 26,850). More than 26 million people in DRC face acute food insecurity, with roughly 1 million internally displaced in Ituri province alone.
• No fresher case count was found for Aug 27–31; ECDC's page states its next update was due today (Aug 31) but was not yet published at time of research. The Ervebo vaccination campaign launched in Kisangani Aug 27 has no reported uptake figures yet.

Spin: None

Omissions: None found

Unreported: No English-language reporting was found on how the Ervebo campaign is being received in Kisangani or any early uptake/efficacy signal — WHO itself notes it is unknown whether the vaccine (built for the Zaire strain) protects against the Bundibugyo strain driving this outbreak.

Inaccuracies: None found

What it could mean:

Uganda's and France's formal outbreak closures are genuine good news that risk being lost under the DRC toll's grim case-fatality headline; outlets emphasizing "worst Ebola outbreak in DRC history" may be omitting that containment succeeded outside DRC's own borders — likely ordinary news-value selection (a rising toll is more newsworthy than a quiet regional closure) rather than deliberate suppression.

Inferred; no evidence of intent found.

Where it stands: Active and DRC-only; the last confirmed count is Aug 26 (5,794/2,786), with no confirmed update through Aug 31 despite one being due.

DR Congo Ebola outbreak

• WHO Disease Outbreak News DON616 — https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON616 — primary
• ECDC — https://www.ecdc.europa.eu/en/ebola-outbreak-democratic-republic-congo-and-uganda — primary
• Al Jazeera — (Aug 21, "growing faster, wider… passes 2,500") — reported, stale
• UN News — (Aug 11, "Ebola deaths top 2,000") — reported, stale

• The Democratic Republic of Congo's Ebola outbreak — now the deadliest in the country's history — has reached 5,794 confirmed cases and 2,786 deaths through Aug. 26, the freshest available aggregate (WHO DON615/ECDC).
• Ituri province is the hardest-hit zone, with 4,750 cases and 2,133 deaths across 28 of 36 affected health zones. In all, 54 health zones across 6 provinces are affected, and 808 people are hospitalized in isolation.
• The case fatality rate is holding at roughly 48%, about one death every 30 minutes.
• Uganda's separate outbreak was declared closed by the WHO on Aug. 25, after 42 days with no new case; Uganda had ended transmission on July 28.
• The DRC's vaccination campaign launched Aug. 27: 70,000 Ervebo doses are deploying, 50,000 to frontline and health workers and 20,000 for a Phase 3 trial. Ervebo is licensed against the Zaire strain, not the Bundibugyo strain driving this outbreak, so its protection here is unproven — hence the trial.

Where it stands: The outbreak is still accelerating. The vaccination campaign has just started and trial results are months away. The next PHEIC review will likely turn on whether cases plateau or new clusters emerge.

Spin:

• The WHO, Africa CDC, ECDC and Western media frame it as a public-health emergency and a vaccine-development race.
• The DRC health ministry frames it as an outbreak-control and containment success, pointing to Uganda's closure.
• Some African outlets emphasize the disproportionate toll on health workers and border-region displacement.

Omissions.

• Whether security for health responders — militant activity or community resistance hampering vaccination or treatment access — is a factor was not addressed in today's coverage, a standing gap.
• Why the Bundibugyo strain is driving this specific outbreak remains unexplained.
• Cost and funding for the 70,000-dose campaign, and the pace of trial enrollment, were not reported. No forecast for when the outbreak might peak, or whether it is slowing, is available.

Inaccuracies. None found

What it could mean

• If you already believe vaccines stop Ebola, the strongest evidenced view against it is that Ervebo is not licensed for the Bundibugyo strain — the trial exists precisely because protection is unproven for this virus. Even if it works, 70,000 doses for a multi-zone outbreak across a region of millions means vaccination will be limited to frontline and high-contact workers; full population protection is not on the table.
• Interest in play,
• Documented: the DRC Ministry of Health's and WHO's case-count statements; vaccine manufacturer GSK's Ervebo production capacity.
• Interest in play,
• Inferred: whether health-worker protection and morale drive the outbreak's trajectory — falsifiable if security and PPE improve but cases keep climbing, which would point to community-driven rather than provider-driven transmission.

• The most recent confirmed aggregate remains WHO/ECDC's report through Aug. 25: 5,713 cases and 2,744 deaths; no newer official aggregate was found in today's coverage, so this figure is carried forward as still-current rather than replaced.
• Ituri province remains worst-hit, with 4,750 cases and 2,133 deaths across 28 of 36 health zones; North Kivu has 753 cases and 512 deaths.
• WHO formally declared Uganda's linked outbreak over on Aug. 25, after 42 days with no new confirmed case.
• 770 patients remain hospitalized in isolation; 1,269 have recovered.
• The outbreak remains the deadliest in DRC's history, having surpassed the entire 2018-2020 eastern DRC outbreak's totals within about 12 weeks.

Where it stands: The case count keeps climbing, but no fresher tally has been published since Aug. 25 as of today's check — the next official update is the figure to watch.

Background: an Ervebo vaccination campaign using 70,000 ICG-allocated doses is underway — 50,000 for frontline and health workers, 20,000 for a Phase-3 trial against the Bundibugyo strain, since the licensed vaccine targets the different Zaire strain and protection against Bundibugyo remains scientifically unproven.

Spin: WHO, Africa CDC and the DRC health ministry frame the vaccination rollout and Uganda's declared end as evidence of a coordinated, working response. The Washington Post's on-the-ground reporting (Aug. 26) frames the outbreak as "outpacing containment measures," emphasizing that the response has not kept pace with transmission despite the formal programs.

Omissions. No outlet explains why no fresher aggregate than Aug. 25 has been published, or whether that reflects a genuine reporting lag or a pause in ministry releases. Beyond the WHO/ECDC primary aggregate, no outlet offers independent, on-the-ground verification of the case count.

Inaccuracies. None found

What it could mean. WHO's own DON615 report is the documented primary basis for the case aggregate, dated through Aug. 25. The absence of a fresher aggregate as of today most likely reflects normal reporting cadence rather than data suppression — a reading that would weaken if a materially delayed or missing report pattern continues over the coming days. If the popular read is that the vaccination campaign signals the outbreak is coming under control, the strongest evidenced view against it is the Washington Post's on-the-ground reporting that containment is still being outpaced by transmission, and that protection from the deployed vaccine against this specific strain remains scientifically unproven.

• The confirmed toll reached 5,713 cases and 2,744 deaths through Aug 25 (WHO/ECDC), up 57 cases and 29 deaths from the prior report.
• Ituri province is now the worst-hit — 4,750 cases and 2,133 deaths across 28 of 36 health zones; North Kivu has 753 cases and 512 deaths; 770 patients are in isolation.
• WHO declared the parallel Uganda outbreak over on Aug 25, 42 days after its last case; Uganda itself had declared it ended July 28.
• The Ervebo vaccination campaign that began this week is deploying against a strain the vaccine was not licensed for, so a Phase-3 trial runs alongside it.

Where it stands: The Bundibugyo-strain outbreak is still the deadliest in DR Congo's history and still growing, but the Uganda spillover is contained and vaccination has started.

Background: Aug 26 News.

Spin: The axis is unchanged: WHO and UN framing of vaccination progress and a "turning point" against the raw trajectory, which is still climbing at roughly 50% fatality. Today's addition: the Uganda "outbreak over" milestone lets some coverage lead with good news even as the DR Congo counts underneath keep rising.

Omissions.

• Aggregators still diverge — older snapshots near 5,000 cases / 2,400 deaths are still circulating; the fresh WHO figure supersedes them.
• Whether Ervebo protects against the Bundibugyo strain is unknown. Precisely: no vaccine is proven for THIS strain — not that no vaccine exists — which is why 20,000 of the 70,000 doses go to a trial.

Inaccuracies. None found

What it could mean

• Counter: for readers hearing "vaccination campaign" as the turn, the campaign is partly experimental by design, because protection against this strain is unproven.
• Interest in play:
• Documented — WHO and Africa CDC release the counts and run the trial.
• Inferred — "turning point" language may serve donor mobilization.
• Falsifier: a sustained fall in weekly deaths.

• The Ervebo vaccination campaign is beginning: 70,000 doses allocated by the international coordinating group are being deployed — 50,000 for frontline and health workers, 20,000 for a Phase 3 trial testing the vaccine against the Bundibugyo strain driving this outbreak.
• The latest WHO aggregate counts 5,514 confirmed cases and 2,642 deaths through August 22, a case-fatality rate near half.
• Some outlets still circulated older tallies of about 5,000 cases and roughly 2,400 deaths, which the WHO figure supersedes.
• The outbreak spans 54 health zones across six provinces and has already passed the total deaths of the 2018–2020 eastern DRC epidemic.

Spin: The framing runs between the WHO, Africa CDC and Congo's health ministry, who present the vaccine allocation as a turning point, and the practical caveat that Ervebo's protection against the Bundibugyo strain specifically is unproven — which is why 20,000 of the doses go to a trial rather than straight to the field.

Omissions: Whether Ervebo protects against Bundibugyo at all is unknown — a primary-source caveat easily lost under "vaccine arrives" headlines. Doses actually administered and trial enrollment are not yet reported. Distinctly right-of-center US coverage of the outbreak is thin.

Inaccuracies: None found

What it could mean: If you read "70,000 doses arriving" as containment, the strongest counter is that most doses target an unproven match — Ervebo is licensed against the Zaire strain, not Bundibugyo — so the near-term reality is a trial, not a shield. Interest in play:

Documented — WHO and Africa CDC statements plus the ICG allocation.

Where it stands: The count keeps climbing past every prior DRC outbreak; the vaccine is a test, not yet a turn. Background: 2026-08-25 News.

• A fresh official count landed after days without an update: the DR Congo reported 5,514 confirmed cases and 2,642 deaths through Aug. 22 — up 224 cases and 126 deaths from the Aug. 19 figure.
• The most recent full reporting week recorded 296 deaths, the highest weekly toll to date; health officials put the case-fatality ratio near 50% and the pace at roughly one death every 30 minutes.
• In about twelve weeks the outbreak has already surpassed the total cases and deaths of the 2018–2020 eastern DRC outbreak, which lasted nearly two years.
• The outbreak spans 54 health zones across six provinces, with 808 patients hospitalized in isolation.
• The virus is the Bundibugyo species, for which there is no approved vaccine or treatment; trials of candidate vaccines have been authorized in Canada and the UK, with results months away.

Where it stands: After a break in reporting, the new aggregate confirms continued rapid growth — the deadliest week so far — and no tool yet exists that is proven to stop this strain.

Spin: The division is between the international health bodies and Congo's government that publish the aggregate and the field responders who warn the true spread outruns the count in insecure, conflict-affected zones. The framing is institutional-versus-field, not partisan.

Omissions: The count is reported through Aug. 22, so the most recent days are not yet captured. Vaccination and trial-enrollment numbers are absent from the aggregate. Whether the licensed Ervebo vaccine, approved against the Zaire species, offers any protection against Bundibugyo remains unestablished.

Inaccuracies: None found

What it could mean:

• A fatality ratio near 50% with no proven countermeasure means the toll is driven by transmission speed, not treatment failure alone.
• Documented: the outbreak has surpassed a two-year outbreak's totals in twelve weeks.
• Inferred: without a working vaccine the curve bends only through contact tracing and isolation, which the insecurity undercuts.
• Falsifier: a candidate vaccine showing early protection, or a sharp drop in weekly deaths, would change the picture.

• No new aggregate has been published since the Aug. 20 report, which recorded 5,290 confirmed cases and 2,516 deaths through Aug. 19 — an increase of 81 cases and 40 deaths over the prior report.
• The outbreak now spans 56 of 151 health zones across six provinces; Ituri remains the epicenter with 4,447 cases and 1,984 deaths in 28 of 36 zones, and North Kivu has 663 cases and 452 deaths.
• Of those infected with the Bundibugyo species, 1,152 have recovered and 837 remain hospitalized; 82.9% of identified contacts are under follow-up.
• European disease authorities say the next epidemiological update is due today.

Where it stands: The totals are five days old and cannot be confirmed as current; the reporting cadence itself is the open question, with a fresh official update expected today.

Spin: The division is between the international health bodies and Congo's government that publish the aggregate and the field responders who say counts lag the true spread in insecure, conflict-affected zones. The framing is institutional-versus-field, not partisan.

Omissions: No refreshed count for Aug. 20–23 has been issued by the health ministry, the World Health Organization or European authorities, so today's totals may understate the outbreak. Vaccination and trial-enrollment figures are not in the latest aggregate. Whether the licensed Ervebo vaccine protects against the Bundibugyo species — different from the Zaire species it is approved for — remains unestablished.

Inaccuracies: None found

What it could mean:

• A pause in published counts is not evidence the outbreak has slowed; it more often reflects reporting delays in insecure areas.
• Documented: prior updates came every one to two days, so a five-day gap is a break in cadence.
• Inferred: today's expected update will show continued growth rather than a plateau.
• Falsifier: an official update showing new cases near zero would indicate a real slowdown, not a reporting lag.

Background: 2026-08-22 News.

• No new aggregate has been published since the Aug. 20 report, which recorded 5,290 confirmed cases and 2,516 deaths through Aug. 19 — still the largest and fastest-growing Ebola outbreak on record.
• Ituri remains the epicenter with 4,447 cases and 1,984 deaths across 28 of 36 health zones; North Kivu has 663 cases and 452 deaths.
• The outbreak is caused by the Bundibugyo species; the licensed Ervebo vaccine is proven against the Zaire species, not this one.

Where it stands: The response is still outpaced, and the case and death totals are five days stale because no fresher official update has been issued.

Spin: The division is between international health bodies and Congo's government, which report the aggregate, and the on-the-ground responders who say the counts lag the true spread in conflict-hit zones. The framing is institutional-vs-field, not partisan.

Omissions: No refreshed count for Aug. 20–23 has been issued by the health ministry, WHO or ECDC, so today's totals cannot be confirmed as current — the reporting cadence itself is the gap. Vaccination and trial-enrollment figures are not in the latest aggregate.

Inaccuracies: None found

What it could mean:

• A pause in published counts is not evidence the outbreak has slowed; it more often reflects reporting delays in insecure areas.
• Documented: prior updates came every one to two days, so a five-day gap is a break in cadence.
• Inferred: the next aggregate will show continued growth rather than a plateau.
• Falsifier: an official update showing new cases near zero would indicate a real slowdown, not a reporting lag.

Background: 2026-08-21 News.

• The Democratic Republic of Congo reported 5,290 confirmed cases and 2,516 deaths in data through Aug 19 (reported Aug 20), an increase of 81 cases and 40 deaths day over day.
• Ituri province remains hardest hit with 4,447 cases and 1,984 deaths across 28 of 36 health zones; North Kivu has 663 cases and 452 deaths.
• 1,152 people have recovered and 837 patients are hospitalized in isolation.
• The outbreak, caused by the Bundibugyo species, is the largest ever recorded in the DRC and the fastest-growing Ebola outbreak on record.
• The licensed Ervebo vaccine is approved against the Zaire species; it has not been proven effective against Bundibugyo.

Where it stands: The count keeps climbing faster than containment, and the one available vaccine is not proven against this strain.

Spin: The framing is institutional — WHO, Africa CDC and Congo's health ministry reporting case data and response steps — set against the fact of an outbreak growing faster than the response. The live tension is speed of spread versus speed of containment, plus the open question of whether stockpiled vaccine helps against this species.

Omissions: The death count differs by source — 2,516 (ECDC/WHO aggregate through Aug 19) versus the ~2,378 (Congo health ministry) figure carried a day earlier — and most coverage cites one without reconciling the gap. Security for response teams and who funds the scale-up are thinly covered.

Inaccuracies: Some coverage states flatly there is "no approved vaccine or treatment" (Washington Post, Aug 19) — imprecise: Ervebo is licensed against the Zaire species and exists, but is unproven against Bundibugyo (WHO). The precise fact is that no vaccine is proven for this strain, not that none exists.

What it could mean:

• If you assume the newly allocated Ervebo doses will blunt the outbreak, the strongest evidenced view against it is that the vaccine's efficacy against Bundibugyo is unknown, so deployment is a bet, not a solution.
• Documented: WHO/Africa CDC cleared 70,000 doses (primary, Aug 20).
• Inferred: rising counts partly reflect wider testing, not only faster spread.
• Falsifier: a falling case-fatality rate alongside rising cases would point to detection; a stable ~46% CFR alongside rising cases points to real spread.

• The outbreak stood at 5,021 cases and 2,378 deaths as of Aug 19, a case-fatality rate near 46%.
• It has spread to 54 health zones across six provinces (Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, Bas-Uélé) and is the deadliest in DRC history.
• The international coordinating group cleared an initial 70,000 doses of the Ervebo vaccine from the global stockpile: 20,000 for a Phase 3 trial to test whether it works against this strain, 50,000 for frontline and health workers.
• The pathogen is the Bundibugyo species; Ervebo was developed and licensed against Zaire ebolavirus, and whether it protects against Bundibugyo in humans is not known.
• WHO and Africa CDC said the outbreak is spreading roughly three times faster than the 2014–2016 West Africa epidemic.

Where it stands: The first 70,000 doses are cleared and split between a Phase 3 trial and frontline workers, but the vaccine is unproven against the strain driving the outbreak, and the caseload is still outrunning the response.

Spin: The axis is the WHO, Africa CDC, and the Congolese health ministry against the practical limits of the response. Institutional coverage (WHO and Africa CDC releases, Aug 20; Euronews, Aug 20) frames the vaccine allocation as decisive mobilization. Wire and Left-leaning coverage (NPR, Aug 19; UN News; CNN, Aug 16) foregrounds that the response is being outpaced. There is no meaningful left/right divide on this story.

Omissions: That Ervebo is unproven against Bundibugyo — the strain driving this outbreak — is stated plainly by WHO but muted in the more celebratory framings of the doses' arrival. Attacks on responders in Ituri, carried in earlier coverage, dropped from the vaccine-allocation reports. A daily security picture for health workers is thin across all sources.

Inaccuracies: None found

What it could mean:

• Shipping a vaccine that may not work as a Phase 3 trial rather than a proven countermeasure is the honest structure — it treats deployment as an experiment, not a cure.
• Counter: if the "vaccines are on the way" headline reassures you, the evidenced counter is that the 70,000 doses are unproven against Bundibugyo and the caseload is doubling faster than responders can reach it.
• Documented interest: WHO and Africa CDC have a mandate and a stated aim to generate trial evidence.
• Inferred: highlighting the allocation may serve donor confidence as much as epidemiology.
• Falsifier: trial enrollment and vaccination figures published in coming weeks.

• Congolese data put the Bundibugyo-strain outbreak at about 5,021 cases and 2,378 deaths as of early this week, surpassing the country's 2018–20 Kivu epidemic (about 3,317 cases / 2,287 deaths) to become DR Congo's largest ever.
• Past roughly 2,287 deaths it is the second-deadliest Ebola outbreak on record, behind West Africa's 2014–16 outbreak (about 11,310 deaths).
• It is the fastest-growing on record, spread across six provinces with Ituri the epicenter, where violence has targeted health workers and hampered the response.
• There is no vaccine or treatment approved for the Bundibugyo strain — licensed Ebola vaccines target other strains — and early supportive care is lifesaving.

Spin:

• Axis of division: international health bodies (WHO, ECDC, UN) and Congo's government treating this as a record Central African containment emergency, versus US outlets framing it around a domestic risk assessed as low. Official-versus-audience-proximity, not partisan.
• Institutional telling: record growth, a response gap, and no approved countermeasure.
• US-outlet telling: whether Americans are at risk.

Omissions

• The Congolese-government tally (about 5,021 / 2,378) is not reconciled side by side with the WHO/Africa CDC count, which has lagged the government figure in prior weeks; the dominant telling leads on the higher government number, an interested count that may revise.
• The crude case-fatality rate is rarely stated with its explicit denominator.
• The precise vaccine fact — no countermeasure is approved for the Bundibugyo strain specifically — is stated imprecisely in secondary coverage as "no Ebola vaccine," which is false for the Zaire strain.

Inaccuracies

• None found

What it could mean

• Read this as a distant story, and the load-bearing facts are record growth, a high fatality rate, responders under attack, and no approved countermeasure for this strain.
• Read it as an imminent US threat, and the counter is that spread is concentrated in Central Africa and assessed US domestic risk is low.
• WHO, the UN, and Congo's own tally are not neutral ground: these bodies publish situation reports as donor-mobilization and response-coordination instruments, and a national government has its own reasons to state a record. That weighs the source; it does not make the figures wrong, but it is why the higher government count is carried as a claim, not settled fact.
• Documented: the institutional situation-report function; the Congolese-government tally as the newest, higher, revisable figure; Congo's appeal for resources.
• Inferred: US outlets' low-domestic-risk framing serves audience proximity over proportionate coverage of a record catastrophe.
• That inference is wrong if US outlets run the caseload growth head-on with equal prominence.

(The WHO public-health-emergency declaration for this outbreak was made May 17, 2026; it is background, not today's news.)

• Congolese government data reported for Aug 16 put the Bundibugyo-strain outbreak at about 2,325 deaths, surpassing DR Congo's own 2018–20 epidemic to become the deadliest in the country's history; separate tallies put deaths near 2,378 with confirmed cases over 5,000.
• That makes it the second-largest ever recorded worldwide, behind West Africa's 2014–16 outbreak (about 11,300 deaths).
• It is the fastest-growing on record: about three months to reach 2,000 deaths, against nearly five months for West Africa to reach 1,000.
• No vaccine or treatment is approved for the Bundibugyo strain; licensed Ebola vaccines target other strains, and trials are underway with results months off.
• Weak health infrastructure, community resistance, and worker protests have hampered the response.

Spin:

• Axis of division: international health bodies (WHO, UN, ECDC) and Congo's government treating it as a record Central African emergency, versus US and Western outlets framing it around a domestic risk assessed as low — an institutional-versus-audience-proximity axis, not partisan.
• Institutional telling: record growth, a response gap, and no approved countermeasure for the strain.
• Western-outlet telling: whether Americans are at risk.

Omissions

• The competing tallies are not reconciled side by side: the Congolese-government Aug-16 count (about 2,325 deaths) versus the higher figures (about 2,378 deaths / 5,000-plus cases) and versus any WHO / Africa CDC count. The dominant telling leads on the government number, which is an interested count that may revise.
• The crude case-fatality rate is rarely stated with its explicit denominator.
• The precise vaccine fact — no countermeasure is approved for the Bundibugyo strain specifically, distinct from "no vaccine exists at all" — is stated imprecisely in secondary coverage.
• The record-growth facts rest on institutional primaries (UN, ECDC) plus secondaries that are all left-of-center or state-funded (CNN, Al Jazeera, TRT World); no wire (AP/Reuters) or right/center secondary surfaced.

Inaccuracies

• None found

What it could mean

• Read this as a distant-country story, and the load-bearing facts are the record growth, a high fatality rate, no approved countermeasure for this strain, and transmission off the known chains.
• Read it as an imminent US threat, and the counter is that spread is concentrated in Central Africa and assessed US domestic risk is low.
• The institutional and government figures are not neutral ground: WHO, the UN, and ECDC publish situation reports as donor-mobilization and response-coordination instruments, and a national government has its own reasons to state a record. That weighs the source; it does not make the figures wrong — it is why the higher government count is carried as a claim, not settled fact.
• Documented: the situation-report function of the health bodies; the Congolese-government tally as the newest, highest, and revisable figure.
• Inferred: the Western-outlet low-domestic-risk framing serves audience proximity over proportionate coverage of a record catastrophe.
• That inference is wrong if those outlets run the caseload growth head-on with equal prominence.

• Congolese government data reported for Aug 16 put the Bundibugyo-strain outbreak at about 2,325 deaths and 4,945 confirmed cases, surpassing DR Congo's own 2018–20 epidemic to become the deadliest in the country's history.
• It remains the second-largest ever recorded worldwide, behind West Africa's 2014–16 outbreak (about 11,310 deaths, 28,616 cases).
• It is the fastest-growing on record: about three months to reach 2,000 deaths, against nearly five months for West Africa to reach 1,000.
• No vaccine or treatment is approved for the Bundibugyo strain; licensed Ebola vaccines target other strains, and trials are underway with results months off. Many deaths are occurring outside known transmission chains.

Spin:

• Axis of division: international health bodies (WHO, UN, ECDC) and Congo's government treating it as a record Central African containment emergency, versus US outlets framing it around a domestic risk assessed as low.
• Institutional telling: record growth, a response gap, and no approved countermeasure.
• US-outlet telling: whether Americans are at risk.

Omissions

• The precise vaccine fact — no countermeasure is approved for the Bundibugyo strain specifically, distinct from "no vaccine exists at all" — is stated imprecisely in secondary coverage.
• The two figures are not reconciled side by side: the WHO/Africa CDC as-of Aug 12–13 count (about 2,184 deaths / 4,665 cases) and the higher Congolese-government Aug-16 tally (about 2,325 / 4,945). The dominant telling leads on the higher government number, which is an interested count that may revise.
• The crude case-fatality rate is rarely stated with its explicit denominator.
• No wire (AP/Reuters) or right/center secondary surfaced; the record-growth facts rest on institutional primaries plus left-of-center secondaries.

Inaccuracies

• None found

What it could mean

• Read this as a distant-country story, and the load-bearing facts are the record growth, a high fatality rate, no approved countermeasure for this strain, and transmission off the known chains.
• Read it as an imminent US threat, and the counter is that spread is concentrated in Central Africa and assessed US domestic risk is low.
• The institutional + read some coverage gives WHO, the UN, and Congo's own tally is not neutral ground: these bodies publish situation reports as donor-mobilization and response-coordination instruments, and a national government has its own reasons to state a record. That weighs the source; it does not make the figures wrong — but it is why the higher government count is carried as a claim, not settled fact.
• Documented: the institutional situation-report function; the Congolese-government tally as the newest, higher, and revisable figure.
• Inferred: US outlets' low-domestic-risk framing serves audience proximity over proportionate coverage of a record catastrophe.
• That inference is wrong if US outlets run the caseload growth head-on with equal prominence.

• Congolese government data reported Sunday put the Bundibugyo-strain outbreak at about 2,325 deaths and 4,945 confirmed cases, with 101 new cases in 24 hours — surpassing DR Congo's own 2018–20 epidemic to become the deadliest in the country's history.
• It remains the second-largest ever recorded worldwide, behind only West Africa's 2014–16 outbreak (about 11,310 deaths), which the WHO's chief says this one is "on track to surpass" — a projection, not a current count.
• The outbreak has spread to a sixth province, Bas-Uele.
• No vaccine or treatment is approved for the Bundibugyo strain; licensed Ebola vaccines target other strains, and trials are underway with results months off.

Spin:

• Axis of division: international health bodies (WHO, Africa CDC, ECDC) treating it as a Central African containment emergency, versus US outlets framing it around a domestic risk assessed as low.
• Institutional telling: record growth, sixth-province spread, and a response gap with no approved countermeasure.
• US-outlet telling: whether Americans are at risk.

Omissions

• The precise vaccine fact — no countermeasure is approved for the Bundibugyo strain specifically, distinct from "no vaccine exists at all" — is stated imprecisely in secondary coverage.
• The two figures are not reconciled side by side: the WHO/Africa CDC as-of Aug 12–13 count (about 2,184 deaths / 4,665 cases) and the higher Congolese-government Sunday tally (about 2,325 / 4,945).
• The crude case-fatality rate is rarely stated with its explicit denominator.

Inaccuracies

• None found

What it could mean

• Read this as a distant-country story, and the load-bearing facts are the record growth, a high case-fatality rate, sixth-province spread, and no approved countermeasure for this strain.
• Read it as an imminent US threat, and the counter is that transmission is concentrated in Central Africa and assessed US domestic risk is low.
• Documented: WHO and Africa CDC publish situation reports as response-coordination and donor-mobilization instruments — a reason to weigh the source, not to assume the figures are wrong; the newest higher count is a government tally that may revise.
• Inferred: US outlets' low-domestic-risk framing serves audience proximity over proportionate coverage of a record catastrophe.
• That inference is wrong if US outlets run the caseload growth head-on with equal prominence.

• WHO and Africa CDC figures put the Bundibugyo-strain outbreak at about 4,665 cases and 2,184 deaths as of Aug 12–13 — the fastest-growing on record and the second-largest ever, behind only the 2013–16 West Africa epidemic.
• The outbreak has spread to a sixth province, Bas-Uele, via an imported case from Haut-Uele who died in Buta.
• No vaccine or treatment is approved for the Bundibugyo strain; licensed Ebola vaccines target other strains, and WHO says vaccine trials are now underway, with results months off.
• Africa CDC flagged a new animal-transmission origin for the outbreak.
• The crude case-fatality ratio runs above 44%.

Spin:

• Axis of division: international health bodies (WHO, Africa CDC, ECDC) treating it as a Central African containment emergency versus US outlets framing it around domestic risk, which is assessed low.
• Institutional telling: expanding transmission and a containment response in progress.
• US-outlet telling: whether Americans are at risk.

Omissions

• The precise vaccine fact — no countermeasure is approved for the Bundibugyo strain specifically, distinct from "no vaccine exists at all" — is often stated imprecisely in secondary coverage.
• The evidentiary basis for the "new animal-transmission origin" claim is thin in the relays that carry it.
• No source sets the WHO/Africa CDC figure (as of Aug 12–13) beside any newer daily Congolese count.

Inaccuracies

• Yesterday's telling called this "the largest Ebola outbreak ever recorded"; the current WHO and Africa CDC framing is second-largest ever, behind the 2013–16 West Africa epidemic. The corrected ranking is carried here, to be confirmed against WHO's own wording.

What it could mean

• Read this as a distant-country story, and the load-bearing facts are the record growth, the case-fatality ratio above 44%, spread to a sixth province, and no approved countermeasure for this strain.
• Read it as an imminent US threat, and the counter is that transmission is concentrated in Central Africa and assessed US domestic risk is low.
• Documented: WHO and Africa CDC publish situation reports as response-coordination and donor-mobilization instruments — a reason to weight the source, not to assume the figures are wrong.
• Inferred: US outlets' low-domestic-risk framing serves audience proximity over proportionate coverage of a record catastrophe.
• That inference is wrong if US outlets run the caseload growth head-on with equal prominence.

• The WHO's most recent weekly report (Sitrep 13) put the outbreak at 4,381 cases and 2,011 deaths as of Aug 9, describing "intense and expanding transmission."
• Cumulative deaths crossed 2,000 about 86 days after the outbreak was declared on May 15; the crude case-fatality ratio runs near 44%.
• It has spread from a single Ituri health zone to five provinces and roughly 49 health zones — now the largest Ebola outbreak ever reported in the DRC and the fastest-growing on record.
• No vaccine or treatment is approved for this strain, Bundibugyo ebolavirus; licensed Ebola vaccines target other strains.
• Uganda declared its own linked outbreak over on Jul 28; one linked case reached France, and two Congolese patients were treated in Germany.

Spin:

• Axis of division: how near the threat is — the WHO, Congo's government, ECDC and CDC treat it as a Central African containment emergency, while US outlets frame it around domestic risk (assessed low).
• Institutional telling: expanding transmission and a containment operation in progress.
• Response-NGO telling: Doctors Without Borders foregrounds the scale of the medical effort.
• US-outlet telling: whether Americans are at risk.

Omissions

• The precise vaccine fact — no countermeasure is approved for the Bundibugyo strain specifically, distinct from "no vaccine exists at all" — is often stated imprecisely in secondary coverage.
• The lag between the WHO's weekly report (Aug 9) and any newer daily Congolese count is rarely shown; no source sets the weekly WHO figure beside a daily update.
• The "largest ever in the DRC / fastest-growing on record" superlatives trace to institutional and encyclopedic relays; the WHO's own exact wording is not quoted in most tellings.

Inaccuracies

• None found

What it could mean

• Read as a distant-country story, the load-bearing facts are the record growth, the ~44% fatality rate, and no approved countermeasure for this strain.
• Read as an imminent US threat, the counter is that transmission is concentrated in a few Central African provinces and assessed US domestic risk is low.
• Documented: the WHO and Congo publish situation reports as response-coordination and donor-mobilization instruments — a reason to weight the source, not to assume the figures are wrong.
• Inferred: US outlets' low-domestic-risk framing serves audience proximity over proportionate coverage of a record catastrophe.
• That inference is wrong if US outlets run the caseload growth head-on with equal prominence.

• Congo's Aug 12 update reported 4,566 confirmed cases and 2,128 deaths through Aug 11 — up 117 cases and 67 deaths in a single day, with 570 patients in isolation and 53 of 140 health zones affected across five provinces.
• The WHO's most recent weekly report (Sitrep 13) put it at 4,381 cases / 2,011 deaths as of Aug 9 — a ~2-day-older, lower count.
• Between 60% and 70% of deaths occur in the community, far from care, before patients ever reach a treatment centre.
• It is the fastest-growing Ebola outbreak on record and the second-largest ever, behind only the 2014–16 West African epidemic that killed 11,310.
• No vaccine or treatment is approved for this strain, Bundibugyo ebolavirus; the WHO says trials are under way but results are likely months off.
• Uganda declared its own outbreak over on Jul 28 after 12 case-free days, with two deaths total.

Spin:

• Axis of division: how near the threat is — international health bodies (WHO, Congo's government, ECDC) treat it as an African containment emergency; US outlets treat it as a domestic-risk question.
• WHO and Congo: intense, expanding transmission and a containment operation in progress.
• International wires: why the outbreak is so hard to contain — the community deaths, the remote health zones.
• US outlets: whether Americans are at risk (assessed low).

Omissions

• The daily acceleration (+117 cases / +67 deaths in one day) is in the Congo update but appears in little secondary coverage.
• The WHO (2,011, Aug 9) versus Congo (2,128, Aug 11) tally gap: each report used one figure; set side by side almost nowhere.
• The community-death share (60–70% dying before reaching care) is central to why the count keeps climbing, yet rarely foregrounded.

Inaccuracies

• None found

What it could mean

• Read as a distant event, the load-bearing facts are the ~46% fatality rate, the record growth, and no approved countermeasure for this strain.
• Read as a US-risk question, the low-risk expert assessments are the answer.
• The community-death share means official counts likely undercount, not overcount — the deaths happening outside clinics are the hardest to tally.
• The WHO's figures are self-reported by a body whose report states a fundraising aim — a reason to weight the source, not to assume the numbers are wrong.
• This reading is wrong if a US outlet runs the acceleration numbers and the tally gap head-on, or if community deaths turn out double-counted.

• 4,381 cases and 2,011 deaths as of Aug 9, a 46% fatality rate.
• Up 579 cases and 304 deaths in the prior week — the steepest one-week rise recorded for this outbreak.
• Congo's government puts the toll higher, at 2,061 deaths.
• No vaccine or treatment is approved for this strain, Bundibugyo ebolavirus.

Spin:

• Axis of division: how near the threat is — international health authorities treat it as an African containment emergency; US outlets treat it as a domestic-risk question.
• WHO: a containment operation in progress.
• AP: why containment is hard on the ground.
• Fox: what Americans should know about their own exposure.
• Newsweek: whether it could arrive in the US.

Omissions

• The one-week jump (+579 cases / +304 deaths) is in the WHO report but appears in no US coverage.
• The higher Congo toll (2,061) and the lower WHO toll (2,011): each camp used one figure and set the gap out nowhere. Congo's toll reported by UN News (Aug 12); the WHO figure used by the US outlets.

Inaccuracies

• None found

What it could mean

• Read as a distant event, the load-bearing facts are the 46% fatality rate and the absence of an approved vaccine.
• Read as a US-risk question, the low-risk expert assessments are the answer.
• The WHO's figures are self-reported by a body whose report states a fundraising aim — a reason to weight the source, not to assume the numbers are wrong.
• This reading is wrong if a US outlet runs the acceleration numbers and the tally gap head-on.